Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

Q1 2025 Earnings Call Transcript February 6, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.65, ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

A high school quarterback and UNC Tar Heel fan, Noah Gray overcame Type 1 diabetes to star for the Duke Blue Devils before ...

Sen. FETTERMAN on Trump saying the US will "take over" the Gaza strip and relocate all Palestinians while area is rebuilt: ...

Circadian rhythm fasting may boast a few benefits, like helping improve body composition, sleep, and more. But is it worth ...

Hamlet” (the original) was written, of course, in 1600s vintage English blank verse; much of “Fat Ham” is in Black English ...

Some of the best health care stocks for February 2025, based on 30-day returns, include Akero Therapeutics Inc., Guardant Health Inc., and Inari Medical Inc. The best-performing health care stocks in ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...